-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, G59WLX4Z0aS0UgoDmNIdP4mXHj/uPEymDZiA91QxVbZKUUu2f6Pkg9yTJseSI1jq 3AmocUyqWoodxJ1ghVDADw== 0000930413-07-008085.txt : 20071019 0000930413-07-008085.hdr.sgml : 20071019 20071019211244 ACCESSION NUMBER: 0000930413-07-008085 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20071017 FILED AS OF DATE: 20071019 DATE AS OF CHANGE: 20071019 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ENZO BIOCHEM INC CENTRAL INDEX KEY: 0000316253 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-MEDICAL LABORATORIES [8071] IRS NUMBER: 132866202 STATE OF INCORPORATION: NY FISCAL YEAR END: 1106 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 BUSINESS PHONE: 5167555500 MAIL ADDRESS: STREET 1: ENZO BIOCHEM INC STREET 2: 60 EXECUTIVE BLVD CITY: FARMINGDALE STATE: NY ZIP: 11735 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: RABBANI SHAHRAM K CENTRAL INDEX KEY: 0000901501 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-09974 FILM NUMBER: 071182066 BUSINESS ADDRESS: STREET 1: 60 EXECUTIVE BOULEVARD CITY: FARMINGDALE STATE: NY ZIP: 11735 4 1 c50828_ex.xml X0202 4 2007-10-17 0 0000316253 ENZO BIOCHEM INC ENZ 0000901501 RABBANI SHAHRAM K C/O ENZO BIOCHEM, INC. 527 MADISON AVENUE NEW YORK NY 10022 1 1 0 0 Treasurer and Secretary Common Stock 2007-10-17 4 S 0 27300 13.1044 D 2162440 D Common Stock 2007-10-18 4 S 0 80800 13.0346 D 2081640 D As of the date hereof, the Reporting Person has a direct beneficial ownership interest in: (a) 1,354 shares of Common Stock held in the name of the Reporting Person's son; (b) 1,671 shares of Common Stock that the Reporting Person holds as custodian for certain of his nephews; (c) 4,180 shares of Common Stock held in the Issuer's 401(k) plan; and (d) stock options to purchase 523,342 shares of Common Stock. The Reporting Person also owns 7,000 Restricted Stock Units that will not vest within the next 60 days. /s/ Shahram K. Rabbani 2007-10-19 -----END PRIVACY-ENHANCED MESSAGE-----